EarCentric EX2 vs Resound Vivia 9 60S microRIE

The EarCentric EX2 is a behind-the-ear prescription hearing aid priced at $218, positioning it as a budget-friendly option in the prescription category. In HearAdvisor's lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking #35 of 39 prescription hearing aids tested. This 2021 release demonstrates mixed performance across key metrics. Its standout strength is feedback handling, scoring an excellent 4.7/5—essentially matching the category average and indicating reliable stability during movement. However, speech performance is a significant weakness: speech in quiet scores just 1.0/5 (2.40 points below the category average of 3.40), and speech in noise scores 1.0/5 (1.11 points below average). These low absolute scores suggest limited audibility enhancement in our standardized test conditions. Own-voice comfort scores 2.3/5, which is mixed in absolute terms and 0.40 points below the category average. Music streaming scored 0.0/5, indicating this device is not suited for audio entertainment purposes. The EarCentric EX2 may appeal to budget-conscious consumers who prioritize cost over performance, but alternatives exist at similar or lower price points with stronger test results. The RxEars Rxi, available in the same price range, scored 4.07/5 in our testing. Consumers seeking entry-level amplification should weigh the significant speech clarity limitations against the low purchase price.

The ReSound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In our lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #29 of 39 prescription hearing aids tested. This device shows a mixed performance profile. Its standout strength is own-voice comfort, scoring 3.4/5—a solid result that sits 0.70 points above the category average. Speech clarity in quiet environments also performs at category average with a score of 3.4/5. Feedback handling is strong in absolute terms at 4.2/5, though this falls 0.52 points below the category average, reflecting the high bar set by competing prescription devices. The Vivia 9's most notable weakness is speech understanding in noisy environments, where it scored just 1.1/5—a low result that trails the category average by 0.96 points. Music streaming performance is mixed at 2.6/5, sitting slightly below average. These limitations are worth considering given the premium price positioning. For listeners who prioritize comfortable own-voice perception and primarily encounter quieter listening situations, the Vivia 9 may be suitable. However, those frequently in challenging noise environments should note that several alternatives in this price range—including the Phonak Sphere Infinio and Oticon Intent—deliver stronger overall performance in our testing. Budget-conscious shoppers may also find comparable sound quality at lower price points with options like the Jabra Enhance Pro 20 at Costco.